$ALNY
ALNYLAM PHARMACEUTICALS, INC.

2013 Q4 Form 10-Q Financial Statement

#000119312513431609 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $10.80M $9.000M $16.80M
YoY Change 27.06% -46.43% -19.23%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.300M $6.800M $12.80M
YoY Change -18.63% -46.88% 42.22%
% of Gross Profit
Research & Development $32.10M $34.46M $22.09M
YoY Change 47.93% 55.96% -8.98%
% of Gross Profit
Depreciation & Amortization $2.600M $2.800M $2.300M
YoY Change 30.0% 21.74% 76.92%
% of Gross Profit
Operating Expenses $40.44M $41.23M $34.91M
YoY Change -58.24% 18.1% 5.05%
Operating Profit -$32.23M -$18.15M
YoY Change 77.63% 45.9%
Interest Expense $300.0K $300.0K -$1.400M
YoY Change -142.86% -121.43% 600.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $278.0K -$1.355M
YoY Change -100.0% -120.52% 69.59%
Pretax Income -$29.30M -$31.96M -$19.50M
YoY Change -59.75% 63.86% 47.74%
Income Tax $3.000M -$2.270M $0.00
% Of Pretax Income
Net Earnings -$32.36M -$29.69M -$19.50M
YoY Change -47.97% 52.22% 47.33%
Net Earnings / Revenue -299.6% -329.84% -116.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$515.1K -$476.0K -$378.6K
COMMON SHARES
Basic Shares Outstanding 63.43M shares 62.96M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $245.9M $193.8M $228.3M
YoY Change 100.2% -15.13% 31.99%
Cash & Equivalents $53.17M $11.84M $75.84M
Short-Term Investments $192.7M $181.9M $152.5M
Other Short-Term Assets $3.900M $4.800M $5.700M
YoY Change 50.0% -15.79% 16.33%
Inventory
Prepaid Expenses
Receivables $4.200M $600.0K $1.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $254.0M $199.2M $235.9M
YoY Change 102.32% -15.58% 31.07%
LONG-TERM ASSETS
Property, Plant & Equipment $16.45M $16.97M $18.79M
YoY Change -16.93% -9.67% 22.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $150.1M $231.4M -$2.755M
YoY Change 5.56% -8499.27% -102.4%
Other Assets
YoY Change
Total Long-Term Assets $166.5M $248.3M $86.42M
YoY Change 2.8% 187.37% -33.63%
TOTAL ASSETS
Total Short-Term Assets $254.0M $199.2M $235.9M
Total Long-Term Assets $166.5M $248.3M $86.42M
Total Assets $420.5M $447.5M $322.4M
YoY Change 46.26% 38.82% 3.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.896M $2.728M $5.093M
YoY Change 33.39% -46.44% -7.4%
Accrued Expenses $14.16M $15.39M $14.91M
YoY Change 22.51% 3.16% 22.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.86M $54.90M $54.76M
YoY Change 11.42% 0.25% -41.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $96.30M $95.00M $521.0K
YoY Change -8.37% 18134.17% -99.41%
Total Long-Term Liabilities $96.30M $95.00M $521.0K
YoY Change -8.37% 18134.17% -99.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.86M $54.90M $54.76M
Total Long-Term Liabilities $96.30M $95.00M $521.0K
Total Liabilities $150.2M $149.9M $145.2M
YoY Change -2.14% 3.26% -20.4%
SHAREHOLDERS EQUITY
Retained Earnings -$596.2M -$563.9M -$444.8M
YoY Change 17.6% 26.76%
Common Stock $846.9M $834.3M $621.9M
YoY Change 35.41% 34.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $270.3M $297.6M $177.2M
YoY Change
Total Liabilities & Shareholders Equity $420.5M $447.5M $322.4M
YoY Change 46.26% 38.82% 3.92%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$32.36M -$29.69M -$19.50M
YoY Change -47.97% 52.22% 47.33%
Depreciation, Depletion And Amortization $2.600M $2.800M $2.300M
YoY Change 30.0% 21.74% 76.92%
Cash From Operating Activities -$22.40M -$21.70M $5.200M
YoY Change -67.49% -517.31% -117.93%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K -$900.0K -$5.800M
YoY Change 50.0% -84.48% 1833.33%
Acquisitions
YoY Change
Other Investing Activities $56.90M -$1.500M $23.60M
YoY Change 28.73% -106.36% -35.34%
Cash From Investing Activities $56.10M -$2.600M $17.90M
YoY Change 28.97% -114.53% -50.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.600M 11.10M 4.500M
YoY Change 660.0% 146.67%
NET CHANGE
Cash From Operating Activities -22.40M -21.70M 5.200M
Cash From Investing Activities 56.10M -2.600M 17.90M
Cash From Financing Activities 7.600M 11.10M 4.500M
Net Change In Cash 41.30M -13.20M 27.60M
YoY Change -269.26% -147.83% 278.08%
FREE CASH FLOW
Cash From Operating Activities -$22.40M -$21.70M $5.200M
Capital Expenditures -$900.0K -$900.0K -$5.800M
Free Cash Flow -$21.50M -$20.80M $11.00M
YoY Change -68.52% -289.09% -138.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63430076 shares
CY2013Q1 us-gaap Share Price
SharePrice
20.13
CY2012Q1 us-gaap Share Price
SharePrice
10.75
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75838000
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63236216 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63236216 shares
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
91779000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
54895000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
27168000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2728000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
297582000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
833660000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563878000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33558000
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15386000
CY2013Q3 us-gaap Liabilities
Liabilities
149921000
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3247000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
632000
CY2013Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1200000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
447503000
CY2013Q3 us-gaap Available For Sale Securities Equity Securities Noncurrent
AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
57999000
CY2013Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
181939000
CY2013Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
173366000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16974000
CY2013Q3 us-gaap Assets
Assets
447503000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11840000
CY2013Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
355376000
CY2013Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
355305000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4776000
CY2013Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
609000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
199164000
CY2013Q3 alny Accrued Intraperiod Tax Allocation
AccruedIntraperiodTaxAllocation
2023000
CY2013Q3 alny Availableforsale Debt Securities Gross Unrealized Loss Accumulated In Investments
AvailableforsaleDebtSecuritiesGrossUnrealizedLossAccumulatedInInvestments
164000
CY2013Q3 alny Availableforsale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableforsaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
93000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70228000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52489936 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52489936 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
100874000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19799000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
48345000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15662000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4420000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
134053000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
624876000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-507010000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31417000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11558000
CY2012Q4 us-gaap Liabilities
Liabilities
153467000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4248000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
525000
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
950000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287520000
CY2012Q4 us-gaap Available For Sale Securities Equity Securities Noncurrent
AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
38748000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
71407000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
103416000
CY2012Q4 us-gaap Assets
Assets
287520000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51405000
CY2012Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
174889000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
174823000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2641000
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
104000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
125557000
CY2012Q4 alny Availableforsale Debt Securities Gross Unrealized Loss Accumulated In Investments
AvailableforsaleDebtSecuritiesGrossUnrealizedLossAccumulatedInInvestments
97000
CY2012Q4 alny Availableforsale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableforsaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
31000
dei Trading Symbol
TradingSymbol
ALNY
dei Entity Registrant Name
EntityRegistrantName
ALNYLAM PHARMACEUTICALS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001178670
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61103000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46288000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8614000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 13%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect&#xA0;the reported amounts of assets and liabilities and&#xA0;the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and&#xA0;the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap License And Services Revenue
LicenseAndServicesRevenue
36320000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11506000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.93
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3128000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62584000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
335197000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
115000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45362000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2222000
us-gaap Investment Income Net
InvestmentIncomeNet
784000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63350000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-192000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
505000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
766000
us-gaap Net Income Loss
NetIncomeLoss
-56868000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3871000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18819000
us-gaap Restricted Stock Expense
RestrictedStockExpense
2600000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
193276000
us-gaap Share Based Compensation
ShareBasedCompensation
15297000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-39565000
us-gaap Operating Expenses
OperatingExpenses
99670000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5716000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6954000
us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
-5716000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1336000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
173572000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7602000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
151772000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-186553000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80851000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
19819000
alny Non Cash Stock Based Compensation Expenses Research And Development
NonCashStockBasedCompensationExpensesResearchAndDevelopment
11092000
alny Non Cash Stock Based Compensation Expenses General And Administrative
NonCashStockBasedCompensationExpensesGeneralAndAdministrative
4205000
alny Charge For Four Zero One K Company Stock Match
ChargeForFourZeroOneKCompanyStockMatch
351000
alny Investments Classified As Cash And Cash Equivalent Original Maturities
InvestmentsClassifiedAsCashAndCashEquivalentOriginalMaturities
P90D
alny Investment Maturity Period Minimum
InvestmentMaturityPeriodMinimum
P90D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49772000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46697000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8794000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.88
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3641000
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
179000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7662000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
162000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
58230000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
273000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43826000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
195672000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
167000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
328000
us-gaap Investment Income Net
InvestmentIncomeNet
755000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-24668000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-707000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
86800000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7011000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
163357000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40139000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1359000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43553000
us-gaap Operating Income Loss
OperatingIncomeLoss
-41107000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-1214000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
450000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2719000
us-gaap Net Income Loss
NetIncomeLoss
-43826000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2678000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34446000
us-gaap Restricted Stock Expense
RestrictedStockExpense
1900000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92446000
us-gaap Share Based Compensation
ShareBasedCompensation
9638000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5610000
us-gaap Operating Expenses
OperatingExpenses
99337000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64891000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5974000
alny Non Cash Stock Based Compensation Expenses Research And Development
NonCashStockBasedCompensationExpensesResearchAndDevelopment
6357000
alny Non Cash Stock Based Compensation Expenses General And Administrative
NonCashStockBasedCompensationExpensesGeneralAndAdministrative
3281000
alny Charge For Four Zero One K Company Stock Match
ChargeForFourZeroOneKCompanyStockMatch
310000
CY2012Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8625000 shares
CY2012Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
86800000
CY2012Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
5900000
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9200000 shares
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
173600000
CY2013Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
11600000
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51542000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8794000 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1613000
CY2012Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
16759000
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
170000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19502000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2012Q3 us-gaap Investment Income Net
InvestmentIncomeNet
261000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19332000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18147000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1355000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32234000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
278000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-29686000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6768000
CY2013Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
1300000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-19502000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12812000
CY2012Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
700000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
34906000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22094000
CY2012Q3 alny Non Cash Stock Based Compensation Expenses Research And Development
NonCashStockBasedCompensationExpensesResearchAndDevelopment
2271000
CY2012Q3 alny Non Cash Stock Based Compensation Expenses General And Administrative
NonCashStockBasedCompensationExpensesGeneralAndAdministrative
1115000
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62416000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8614000 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2013Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
8991000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-962000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31956000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000
CY2013Q3 us-gaap Investment Income Net
InvestmentIncomeNet
290000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30648000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
41225000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2270000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34457000
CY2013Q3 alny Non Cash Stock Based Compensation Expenses Research And Development
NonCashStockBasedCompensationExpensesResearchAndDevelopment
6805000
CY2013Q3 alny Non Cash Stock Based Compensation Expenses General And Administrative
NonCashStockBasedCompensationExpensesGeneralAndAdministrative
2040000

Files In Submission

Name View Source Status
0001193125-13-431609-index-headers.html Edgar Link pending
0001193125-13-431609-index.html Edgar Link pending
0001193125-13-431609.txt Edgar Link pending
0001193125-13-431609-xbrl.zip Edgar Link pending
alny-20130930.xml Edgar Link completed
alny-20130930.xsd Edgar Link pending
alny-20130930_cal.xml Edgar Link unprocessable
alny-20130930_def.xml Edgar Link unprocessable
alny-20130930_lab.xml Edgar Link unprocessable
alny-20130930_pre.xml Edgar Link unprocessable
d599634d10q.htm Edgar Link pending
d599634dex12.htm Edgar Link pending
d599634dex311.htm Edgar Link pending
d599634dex312.htm Edgar Link pending
d599634dex321.htm Edgar Link pending
d599634dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending